Clinical Trial Update: Drug Use Investigation of Kovaltry in Hemophilia A Patients

View source ↗

Summary

This document reports the completion of a drug-use investigation evaluating Kovaltry for Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Kovaltry (octocog alfa)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED